(Q33372731)

26 July 2017

Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world (English)

1 reference

26 July 2017

0 references

1 reference

Elisa Sobreira

1

1 reference

26 July 2017

Ricardo F Pires

series ordinal

2

1 reference

26 July 2017

Marta Cizmarik

series ordinal

3

1 reference

26 July 2017

Gregory A Grabowski

series ordinal

4

1 reference

26 July 2017

language of work or name

1 reference

25 September 2006

1 reference

Molecular Genetics and Metabolism

26 July 2017

1 reference

26 July 2017

90

1 reference

26 July 2017

1

1 reference

26 July 2017

81-86

1 reference

The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

Skeletal aspects of Gaucher disease: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

Gaucher disease: lessons from a decade of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

Prediction of severity of Gaucher's disease by identification of mutations at DNA level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

Enzyme therapy for Gaucher disease: the first 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

Factors associated with Hb concentration in children aged 6-59 months in the State of Pernambuco, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

Childhood anemia prevalence and associated factors in Salvador, Bahia, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

Iron deficiency anemia in children: a challenge for public health and for society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.009

10.1016/J.YMGME.2006.08.009

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference